Bioconjugation techniques are a powerful tool in the development of new biotechnologies such as biosensors, advanced drug-delivery systems, and more. However, given the complexity of bioconjugation chemistry, it’s no surprise that many challenges need to be overcome when developing bioconjugation techniques. In this article, we discuss some of the common bioconjugation problems and their solutions.
Common bioconjugation problems include lack of site-specificity, biomolecule degradation, and unstable bioconjugates. Common solutions include using activating biomolecules to open up specific sites, using less-harsh reagents, and storing bioconjugates in cool conditions.
When you need to combine different biomolecules you need to utilize bioconjugation techniques.
Bioconjugation is the formation of new molecules by combining two or more different molecules, one or more of which is a biomolecule.
Commonly used biomolecules for bioconjugation reactions include proteins, DNA, antibodies, and more. These biomolecules can be attached to a range of molecules such as plastics, nanoparticles, metals, drugs, fluorescent molecules, and many others.
The applications of bioconjugates are wide and varied. Bioconjugates are often used in advanced drug-delivery systems and therapies, novel biosensors used in medical science, biological and medical imaging, and more.
Related articles:
Proteins are often used in bioconjugation chemistry. There are many reasons for this including biological monitoring by labelling live proteins, creating protein biosensors, stabilizing proteins in protein therapies, and imaging. Some proteins are relatively easy to work with and can be manipulated for bioconjugation chemistry on a larger-scale. However, others may prove difficult and several problems might need to be faced.
Bioconjugation problems related to proteins include lack of access to the reaction site, lack of site-specificity, and a lack of bioconjugation techniques for different amino acids.
Often, when dealing with native proteins, the desired reactive groups are limited or inaccessible for reactions due to the structure and folding of the protein. This can lead to poor yields of the bioconjugate product or, worse, a failure of the reaction. This problem is arguably the most difficult to overcome if your goal is to retain the native nature of the protein. Thus, creative solutions to the problem are required.
Here are some possible solutions:
Most proteins and antibodies have readily available amines and carboxyls. You can label proteins and antibodies with these conjugation kits to save time and improve consistency between experiments.
In some cases, your bioconjugation may lack site-specificity. This means that you’re not able to only target the specific reaction site you desire for your bioconjugation reaction. Here are some ways to overcome this problem:
Sadly, there isn’t always a bioconjugation technique available for your specific purpose. No-one may have performed the specific reaction that you’re interested in or used the amino acid that you have in mind. For example, tyrosine is only recently emerging as a bioconjugation target. We’ve described some methods for tryptophan bioconjugation and methionine bioconjugation in our other articles.
If this is the case, your best option is to either start performing some research of your own to assess whether your desired technique is possible or look for an alternative solution such as using a different amino acid or different chemical reaction.
Antibody bioconjugates have seen a significant amount of research in the field of bioconjugation science. This is because of their fascinating potential in biological imaging and immunohistochemistry. However, because of their fragile and complicated nature, there are often problems with creating bioconjugates with antibodies.
Problems with antibody bioconjugation techniques include degradation of the antibody due to harsh reagents and instability of the bioconjugate product.
When trying to produce stable chemical bonds that will form the link between an antibody and another molecule, harsh chemicals can often cause the antibody to degrade. This results in an unusable bioconjugate in many cases. Here are some ways of overcoming this problem:
If you’re successful in synthesizing your antibody bioconjugate, you might run into issues with its stability. Just like storing antibodies on their own, the conjugate may begin to decompose immediately or later on during storage. This is a difficult challenge, and the shelf-life of your conjugate product will vary depending on its specific properties. However, there are a few things you can do to extend the life of your antibody bioconjugate product:
Antibody-enzyme conjugates have seen significant research in the area of immunohistochemistry and cancer-therapy. They offer unique ways to fight against cancers through precise targeting and high activity against cancer cells.
Problems with antibody-enzyme conjugates include controlling linker length and degradation of enzyme activity due to the reagents used.
Trying to attach molecules together? You can explore conjugation kits to help you attach biomolecules together quickly and repeatably here.
Controlling linker length is important for antibody-enzyme conjugates because it can affect the bioconjugates stability and reactivity. Linkers can range from “zero-length” crosslinkers which are as short as effectively possible to extended length chains. If the linker is too short, it can hinder the enzyme’s activity. If the linker is too long, it may be unstable. Here are some solutions to controlling linker length:
Enzymes can be negatively affected by the reagents and conditions used in bioconjugation reactions. This can affect their enzymatic activity and potentially limit their active life. Here are some solutions to overcome this problem when synthesizing antibody-enzyme conjugates:
DNA and protein structures are two of the most important classes of biomacromolecules in biology. The bioconjugation of these structures opens up many new options which combine the proteins of both DNA and proteins. This gives access to tools such as molecular recognition, enzymatic catalysis, and structural hybridization. However, there are numerous challenges you might face when creating protein-DNA bioconjugates. We discuss DNA bioconjugation techniques in more detail in another article.
Bioconjugation problems with protein-DNA conjugation techniques include the introduction of reaction sites to the DNA and low reaction yields.
The conjugation of DNA to a protein isn’t always straightforward. It often requires the introduction of reaction sites to the DNA structure which can be challenging depending on your applications. Here are some solutions to the problem of needing to introduce reaction sites on DNA:
When synthesizing protein-DNA conjugates, one of the most frustrating problems you can face is low reaction yields. The reaction is working but it is only producing a small amount of your desired bioconjugate compound. Here are some ways to overcome this:
We discuss how western blot negative controls improve western blotting technique and results, while providing…
We discuss best practices for determining sample loading quantities for western blots and give tips…
We discuss optimization of western blot exposure time and detection and provide protocols for detection…
We discuss bioconjugation linkers and their applications while providing tips and tricks to maximize bioconjugation…
We discuss applications involving nanobody bioconjugation and provide protocols, tips and tricks to maximize nanobody…
We discuss the structure of polymer brushes, protocols for bioconjugation of polymer brushes, and applications…